drugset / Trial / NCT03208894

Role of Salbutamol and Furosemide in TTN

NCT03208894

Phase 3 Completed 100 enrolled Armed Forces Hospital, Pakistan
RandomizedParallel-groupSingle-blindTreatment

Summary

to see the effects of slabutamol and IV furosemide in the treatment of transient tachypnea of newborn

Timeline

Start
2016-11-01
Primary completion
2017-05-30
Completion
2017-06-30

Drugs

EvaluationDrugModalityDoseRoute
Subject Furosemide Other / unclassified Intravenous
Subject Salbutamol Unknown Inhaled